TapewireFind a company

person · Reporting owner

DELANEY MARK E

Disclosed activity across 1 company

Tapewire entity
28087
SEC CIK
0001955265

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
QUEST DIAGNOSTICS INCDGX · Entity 2118SVP & Chief Commercial OfficerJuly 28, 2026July 29, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

QUEST DIAGNOSTICS INC

Report date July 28, 2026 · Filed July 29, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect10,335 Reported balance After 2026-07-28 transaction · row 1
1 source row

Row 1 · 2026-07-28 · Sale · Disposed 1,600 · Balance 10,335

F1: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

Filing footnotes · ownership attribution and instrument terms

F1: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
July 28, 2026 Filed Jul 29, 2026 21:04 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 1,600 $235.18 $376,288.00
Disclosure

SEC source: 0001022079-26-000087 · wk-form4_1785359086.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,335

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

Read SEC document
July 22, 2026 Filed Jul 27, 2026 20:32 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 OtherCommon Stock 34 $206.81 $7,031.44
Disclosure

SEC source: 0001022079-26-000079 · wk-form4_1785184364.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,935

F1 · security: Represents an award of restricted share units.

F2 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

Read SEC document
April 20, 2026 Filed Apr 24, 2026 22:23 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 OtherCommon Stock 37 $194.70 $7,203.75
Disclosure

SEC source: 0001022079-26-000044 · wk-form4_1777069381.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,901

F1 · security: Represents an award of restricted share units.

F2 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

Read SEC document
March 04, 2026 Filed Mar 6, 2026 21:44 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 2,326 $204.86 $476,504.36
Disclosure

SEC source: 0001022079-26-000030 · wk-form4_1772833481.xml · nonDerivative · entry 2

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,864

F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.

Read SEC document
March 04, 2026 Filed Mar 6, 2026 21:44 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 5,682 $204.86 $1,164,014.52
Disclosure

SEC source: 0001022079-26-000030 · wk-form4_1772833481.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,190

F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:37 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 188 $204.86 $38,513.68
Disclosure

SEC source: 0001022079-26-000018 · wk-form4_1772660249.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,508

F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 22:10 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantNon-Qualifed Stock Option (right to buy) · Derivative 7,332 $0.00 Strike: $204.96 $0.00
Disclosure

SEC source: 0001955265-26-000002 · wk-form4_1771625397.xml · derivative · entry 5

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,332

Underlying: Common Stock · 7,332 shares

Expires 2036-02-18

F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 22:10 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 230 $206.99 $47,607.70
Disclosure

SEC source: 0001955265-26-000002 · wk-form4_1771625397.xml · nonDerivative · entry 3

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,681

F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 22:10 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 205 $210.01 $43,052.05
Disclosure

SEC source: 0001955265-26-000002 · wk-form4_1771625397.xml · nonDerivative · entry 2

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,911

F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 22:10 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 1,586 $0.00 $0.00
Disclosure

SEC source: 0001955265-26-000002 · wk-form4_1771625397.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,116

F1 · security: Represents an award of restricted stock units.

Read SEC document
January 28, 2026 Filed Feb 20, 2026 22:10 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 OtherCommon Stock 15 $183.51 $2,752.65
Disclosure

SEC source: 0001955265-26-000002 · wk-form4_1771625397.xml · nonDerivative · entry 4

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,696

F3 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

Read SEC document
November 18, 2025 Filed Nov 20, 2025 21:28 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative 100 $143.33 Strike: $143.33 $14,333.00
Disclosure

SEC source: 0001955265-25-000004 · wk-form4_1763674087.xml · derivative · entry 5

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,484

Underlying: Common Stock · 100 shares

Expires 2033-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

Read SEC document
November 18, 2025 Filed Nov 20, 2025 21:28 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative 7,846 $144.47 Strike: $144.47 $1,133,511.62
Disclosure

SEC source: 0001955265-25-000004 · wk-form4_1763674087.xml · derivative · entry 4

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,846 shares

Expires 2032-03-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

Read SEC document
November 18, 2025 Filed Nov 20, 2025 21:28 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 7,946 $187.35 $1,488,683.10
Disclosure

SEC source: 0001955265-25-000004 · wk-form4_1763674087.xml · nonDerivative · entry 3

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,530

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

Read SEC document
November 18, 2025 Filed Nov 20, 2025 21:28 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Exercise / conversionCommon Stock 100 $143.33 $14,333.00
Disclosure

SEC source: 0001955265-25-000004 · wk-form4_1763674087.xml · nonDerivative · entry 2

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,476

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

Read SEC document
November 18, 2025 Filed Nov 20, 2025 21:28 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Exercise / conversionCommon Stock 7,846 $144.47 $1,133,511.62
Disclosure

SEC source: 0001955265-25-000004 · wk-form4_1763674087.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,376

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

Read SEC document
October 21, 2025 Filed Oct 24, 2025 22:09 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 15 $189.08 $2,836.16
Disclosure

SEC source: 0001022079-25-000225 · wk-form4_1761343785.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,530

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

Read SEC document
July 21, 2025 Filed Jul 25, 2025 20:26 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 OtherCommon Stock 17 $167.49 $2,847.35
Disclosure

SEC source: 0001022079-25-000184 · wk-form4_1753475171.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,515

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

Read SEC document
May 13, 2025 Filed May 14, 2025 21:12 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 874 $175.31 $153,220.94
Disclosure

SEC source: 0001022079-25-000132 · wk-form4_1747257144.xml · nonDerivative · entry 2

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,498

F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

Read SEC document
May 12, 2025 Filed May 14, 2025 21:12 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 874 $175.72 $153,579.28
Disclosure

SEC source: 0001022079-25-000132 · wk-form4_1747257144.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,372

F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

Read SEC document
April 21, 2025 Filed May 2, 2025 20:30 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 OtherCommon Stock 25 $164.42 $4,110.53
Disclosure

SEC source: 0001022079-25-000126 · wk-form4_1746217832.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,246

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

Read SEC document
March 26, 2025 Filed Mar 28, 2025 20:45 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 256 $166.71 $42,677.76
Disclosure

SEC source: 0001022079-25-000100 · wk-form4_1743194708.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,221

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 21:34 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 1,823 $173.74 $316,728.02
Disclosure

SEC source: 0001022079-25-000086 · wk-form4_1741210490.xml · nonDerivative · entry 2

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,477

F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 21:34 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 5,317 $173.74 $923,775.58
Disclosure

SEC source: 0001022079-25-000086 · wk-form4_1741210490.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,300

F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).

Read SEC document
February 26, 2025 Filed Feb 28, 2025 21:33 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 214 $171.75 $36,754.50
Disclosure

SEC source: 0001022079-25-000069 · wk-form4_1740778392.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,983

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

Read SEC document
February 19, 2025 Filed Feb 21, 2025 21:37 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 242 $169.71 $41,069.82
Disclosure

SEC source: 0001022079-25-000048 · wk-form4_1740173866.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,197

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

Read SEC document
February 12, 2025 Filed Feb 14, 2025 22:26 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantNon-Qualifed Stock Option (right to buy) · Derivative 6,960 $0.00 Strike: $165.30 $0.00
Disclosure

SEC source: 0001022079-25-000032 · wk-form4_1739572003.xml · derivative · entry 2

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,960

Underlying: Common Stock · 6,960 shares

Expires 2035-02-12

F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

Read SEC document
February 12, 2025 Filed Feb 14, 2025 22:26 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 1,815 $0.00 $0.00
Disclosure

SEC source: 0001022079-25-000032 · wk-form4_1739572003.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,439

F1 · security: Represents an award of restricted stock units.

Read SEC document
February 05, 2025 Filed Feb 7, 2025 21:36 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 403 $164.30 $66,214.15
Disclosure

SEC source: 0001022079-25-000020 · wk-form4_1738964173.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,624

Read SEC document
January 29, 2025 Filed Jan 31, 2025 21:28 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 OtherCommon Stock 4 $158.03 $632.10
Disclosure

SEC source: 0001022079-25-000014 · wk-form4_1738358926.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,027

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

Read SEC document
October 21, 2024 Filed Oct 25, 2024 20:27 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 OtherCommon Stock 4 $149.39 $597.55
Disclosure

SEC source: 0001022079-24-000199 · wk-form4_1729888025.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,023

F1 · security: Represents an award of restricted share units.

F2 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

Read SEC document
July 24, 2024 Filed Jul 26, 2024 22:33 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 420 $143.08 $60,093.60
Disclosure

SEC source: 0001022079-24-000168 · wk-form4_1722033208.xml · nonDerivative · entry 2

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,019

Read SEC document
July 22, 2024 Filed Jul 26, 2024 22:33 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 OtherCommon Stock 6 $146.98 $881.90
Disclosure

SEC source: 0001022079-24-000168 · wk-form4_1722033208.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,439

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

Read SEC document
March 26, 2024 Filed Mar 28, 2024 20:52 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 170 $128.11 $21,778.70
Disclosure

SEC source: 0001022079-24-000089 · wk-form4_1711659150.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,433

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.

Read SEC document
February 28, 2024 Filed Mar 1, 2024 21:41 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 225 $126.36 $28,431.00
Disclosure

SEC source: 0001022079-24-000077 · wk-form4_1709329251.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,603

F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units.

Read SEC document
February 14, 2024 Filed Feb 17, 2024 01:02 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantNon-Qualifed Stock Option (right to buy) · Derivative 9,783 $0.00 Strike: $127.81 $0.00
Disclosure

SEC source: 0001022079-24-000030 · wk-form4_1708131743.xml · derivative · entry 2

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,783

Underlying: Common Stock · 9,783 shares

Expires 2034-02-14

F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

Read SEC document
February 14, 2024 Filed Feb 17, 2024 01:02 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 2,348 $0.00 $0.00
Disclosure

SEC source: 0001022079-24-000030 · wk-form4_1708131743.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,828

F1 · security: Represents an award of restricted share units.

Read SEC document
March 24, 2023 Filed Mar 27, 2023 20:38 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 170 $134.25 $22,822.50
Disclosure

SEC source: 0001022079-23-000073 · wf-form4_167994948437526.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,480

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 21:39 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantNon-Qualifed Stock Option (right to buy) · Derivative 7,584 $0.00 Strike: $143.33 $0.00
Disclosure

SEC source: 0001022079-23-000029 · wf-form4_167753393895974.xml · derivative · entry 2

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,584

Underlying: Common Stock · 7,584 shares

Expires 2033-02-23

F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 21:39 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 1,919 $0.00 $0.00
Disclosure

SEC source: 0001022079-23-000029 · wf-form4_167753393895974.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,650

F1 · security: Represents an award of restricted share units.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.